Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yalu Zhang
Qiaofei Liu
Jingkai Liu
Quan Liao
机构：
[1] Peking Union Medical College Hospital,Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases
[2] Chinese Academy of Medical Science and Peking Union Medical College,undefined
来源：
Cancer Cell International | / 21卷
关键词：
CD58; Pancreatic ductal adenocarcinoma; Survival; Prognosis; Immune infiltration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
    Zhang, Yalu
    Liu, Qiaofei
    Liu, Jingkai
    Liao, Quan
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma
    Zhang, Shi-Rong
    Li, Hao
    Wang, Wen-Quan
    Jin, Wei
    Xu, Jin-Zhi
    Xu, Hua-Xiang
    Wu, Chun-Tao
    Gao, He-Li
    Li, Shuo
    Li, Tian-Jiao
    Zhang, Wu-Hu
    Xu, Shuai-Shuai
    Ni, Quan-Xing
    Yu, Xian-Jun
    Liu, Lang
    EJSO, 2019, 45 (05): : 769 - 775
  • [3] Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma
    Zhou, Liangjing
    Yu, Leilai
    Ding, Guoping
    Chen, Wenchao
    Zheng, Sixin
    Cao, Liping
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 1141 - 1147
  • [4] Overexpression of protein phosphatase 4 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Weng, Shaofan
    Chen, Weihong
    Stanley, Hamilton R.
    Chatterjee, Deyali
    Katz, Matthew H.
    Lee, Jeffrey E.
    Pisters, Peter W.
    Gomez, Henry F.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    Wang, Hua
    CANCER RESEARCH, 2012, 72
  • [5] Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma
    Wu, Zhengrong
    Zhou, Liangjing
    Ding, Guoping
    Cao, Liping
    CANCER BIOMARKERS, 2017, 18 (01) : 35 - 39
  • [6] Overexpression of MYEOV predicting poor prognosis in patients with pancreatic ductal adenocarcinoma
    Tang, Rui
    Ji, Jianmei
    Ding, Jun
    Huang, Jinxin
    Gong, Biao
    Zhang, Xiwen
    Li, Fu
    CELL CYCLE, 2020, 19 (13) : 1602 - 1610
  • [7] Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Morimachi, Masashi
    Hirabayashi, Kenichi
    Takanashi, Yumi
    Kawanishi, Aya
    Saika, Tsubasa
    Ueyama, Yumiko
    Nakagohri, Toshio
    Nakamura, Naoya
    Suzuki, Hidekazu
    Kagawa, Tatehiro
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (11) : 741 - 745
  • [8] Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma
    Miyazawa, Motoki
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-ichi
    Kitahata, Yuji
    Motobayashi, Hideki
    Sato, Masatoshi
    Yoshimura, Tomohiro
    Ueno, Masaki
    Hayami, Shinya
    Miyamoto, Atsushi
    Shimizu, Atsushi
    Yamaue, Hiroki
    EJSO, 2023, 49 (10):
  • [9] Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Yin, Jingyang
    Guo, Shixiang
    Yang, Jiali
    Xia, Renpei
    Wang, Huaizhi
    PANCREAS, 2025, 54 (01) : e11 - e17
  • [10] High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Han, Hailin
    Wang, Dongmei
    Yang, Maowu
    Wang, Shenhao
    ONCOLOGY LETTERS, 2018, 15 (02) : 2073 - 2078
12345